NNMT has been proposed as a pharmacological target for treating obesity and type 2 diabetes based on higher NNMT expression and plasma MNA levels in individuals with obesity or T2D and animal studies using antisense-oligonucleotide mediated knockdown of NNMT3,4,6. Here, NNMT is linked to type 2 diabetes mellitus.